Yeah its still open at 6.2... LOLGood call on your part. Not...

Yeah its still open at 6.2... LOL

Good call on your part. Not surprising that the AGM was a mixed bag of some very interesting statements, angles and predictable arse-covering. The things to like about what's in the pipeline should start to bear fruit sooner rather than later with the science behind PTX-100 about to speak louder than the sales pitches and excuses.

Progress is being made in areas where progress was not previously intonated as being required "pre-clinically". Nevermind, one can't change the past and It shouldn't come as a surprise that prospective customers need to carry out their own due-dliligence in the lab to test and validate CellPryme. The only upside here is that we are more than 12 mths down the track and 12 mths closer to MTAs being signed. We are very close to the verdict on PTX-100 and hopefully coming out alive from "The Valley of Death" as investors! LOL

So much for two Q&A sessions during the AGM. Maybe Melanie pulled the pin on that as the votes started came in! On notice they are but all could be forgiven this time next year if we rise from the ashes thanks to PTX-100 and a handful of TCL patients lucky enough to live another few months or years.